JP2017189179A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017189179A5 JP2017189179A5 JP2017146473A JP2017146473A JP2017189179A5 JP 2017189179 A5 JP2017189179 A5 JP 2017189179A5 JP 2017146473 A JP2017146473 A JP 2017146473A JP 2017146473 A JP2017146473 A JP 2017146473A JP 2017189179 A5 JP2017189179 A5 JP 2017189179A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- host cell
- virus
- bacterial
- bacterial dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27315109P | 2009-07-31 | 2009-07-31 | |
| US61/273,151 | 2009-07-31 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012522275A Division JP2013500712A (ja) | 2009-07-31 | 2010-07-30 | 逆遺伝学系 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017189179A JP2017189179A (ja) | 2017-10-19 |
| JP2017189179A5 true JP2017189179A5 (enExample) | 2018-02-01 |
| JP6666311B2 JP6666311B2 (ja) | 2020-03-13 |
Family
ID=43018886
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012522275A Withdrawn JP2013500712A (ja) | 2009-07-31 | 2010-07-30 | 逆遺伝学系 |
| JP2015215655A Pending JP2016019547A (ja) | 2009-07-31 | 2015-11-02 | 逆遺伝学系 |
| JP2017146473A Active JP6666311B2 (ja) | 2009-07-31 | 2017-07-28 | 逆遺伝学系 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012522275A Withdrawn JP2013500712A (ja) | 2009-07-31 | 2010-07-30 | 逆遺伝学系 |
| JP2015215655A Pending JP2016019547A (ja) | 2009-07-31 | 2015-11-02 | 逆遺伝学系 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9821052B2 (enExample) |
| EP (1) | EP2459722B1 (enExample) |
| JP (3) | JP2013500712A (enExample) |
| KR (1) | KR20120039047A (enExample) |
| CN (2) | CN102666860B (enExample) |
| AU (1) | AU2010277310B2 (enExample) |
| CA (1) | CA2769673A1 (enExample) |
| WO (1) | WO2011012999A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101323582B1 (ko) | 2011-03-17 | 2013-10-30 | 충북대학교 산학협력단 | Ｖｅｒｏ 세포 유래의 ｐｏｌⅠ 프로모터 및 이를 포함하는 재조합 벡터 |
| WO2013101783A2 (en) | 2011-12-30 | 2013-07-04 | Bio-Rad Laboratories, Inc. | Methods and compositions for performing nucleic acid amplification reactions |
| WO2013087945A2 (en) | 2012-03-02 | 2013-06-20 | Novartis Ag | Influenza virus reassortment |
| US9708585B2 (en) | 2012-12-03 | 2017-07-18 | Seqirus UK Limited | Influenza virus reassortment |
| US20140274806A1 (en) | 2013-03-15 | 2014-09-18 | Synthetic Genomics Vaccines | Influenza virus reassortment |
| CA2898961A1 (en) * | 2013-01-23 | 2014-07-31 | Novartis Ag | Influenza virus reassortment |
| CA2905612A1 (en) | 2013-03-13 | 2014-09-18 | Novartis Ag | Influenza virus reassortment |
| WO2014145261A2 (en) * | 2013-03-15 | 2014-09-18 | University Of Maryland | Methods and compositions for in vivo immune stimulation and antigen production |
| DE202013005130U1 (de) | 2013-06-05 | 2013-09-10 | Novartis Ag | Influenza Virus Reassortierung |
| DE202013005100U1 (de) | 2013-06-05 | 2013-08-26 | Novartis Ag | Influenza Virus Reassortierung |
| CN105722976A (zh) | 2013-06-06 | 2016-06-29 | 诺华股份有限公司 | 流感病毒重配 |
| AU2016242460B2 (en) * | 2015-03-27 | 2019-04-18 | Cadila Healthcare Limited | Recombinant mumps virus Jeryl Lynn 2 based vaccine |
| US10726110B2 (en) * | 2017-03-01 | 2020-07-28 | Seven Bridges Genomics, Inc. | Watermarking for data security in bioinformatic sequence analysis |
| WO2019086463A1 (en) | 2017-10-30 | 2019-05-09 | Baxalta GmbH | Environmentally compatible detergents for inactivation of lipid-enveloped viruses |
| EP3988650A4 (en) | 2019-06-21 | 2022-09-21 | Osaka University | METHOD OF PRODUCING AN ARTIFICIAL RECOMBINANT RNA VIRUS THAT KEEPS A FOREIGN GENE STABLE |
| CN110305854B (zh) * | 2019-07-18 | 2023-09-15 | 山东中医药大学 | 一种携带荧光素酶的重组h3n2亚型流感病毒、构建方法及应用 |
| EP4061930A1 (en) | 2019-11-18 | 2022-09-28 | Seqirus Pty Ltd | Method for producing reassortant influenza viruses |
| CN114395568A (zh) * | 2021-10-29 | 2022-04-26 | 扬州大学 | 一种猪流行性腹泻病毒感染性cDNA克隆及其构建方法与应用 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| WO1995011700A1 (en) | 1993-10-29 | 1995-05-04 | Pharmos Corp. | Submicron emulsions as vaccine adjuvants |
| DE19612966B4 (de) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
| DE19612967A1 (de) | 1996-04-01 | 1997-10-02 | Behringwerke Ag | Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren |
| TW570803B (en) | 1997-04-09 | 2004-01-11 | Duphar Int Res | Influenza vaccine |
| US6274147B1 (en) | 1998-03-31 | 2001-08-14 | University Of Maryland-Biotechnology Institute | Method for generating nonpathogenic infectious pancreatic necrosis virus (IPNV) from synthetic RNA transcripts |
| SK288544B6 (sk) | 1998-06-12 | 2018-03-05 | Mount Sinai School Of Medicine | Geneticky skonštruovaný oslabený chimérny vírus chrípky, vakcinačný prostriedok a farmaceutický prostriedok s jeho obsahom a ich použitie |
| DE69937999T2 (de) | 1998-06-12 | 2009-01-29 | Avir Green Hills Biotechnology Research Development Trade Ag | Interferon induzierende genetisch veränderte attenuierte viren |
| GB9916794D0 (en) * | 1999-07-16 | 1999-09-22 | Isis Innovation | In vitro virus reconstitution |
| PL355287A1 (en) | 1999-09-24 | 2004-04-05 | Smithkline Beecham Biologicals S.A. | Intranasal influenza virus vaccine |
| CA2401117C (en) | 2000-03-03 | 2010-06-29 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell |
| AU5921101A (en) | 2000-04-28 | 2001-11-12 | St Jude Childrens Res Hospital | Dna transfection system for the generation of infectious influenza virus |
| AU2001264802A1 (en) | 2000-05-21 | 2001-12-03 | University Of North Carolina At Chapel Hill | Assembly of large viral genomes and chromosomes from subclones |
| GB0024089D0 (en) | 2000-10-02 | 2000-11-15 | Smithkline Beecham Biolog | Novel compounds |
| EP1361890B1 (en) | 2001-02-23 | 2011-03-30 | GlaxoSmithKline Biologicals s.a. | Influenza vaccine formulations for intradermal delivery |
| WO2002067983A1 (en) | 2001-02-23 | 2002-09-06 | Glaxosmithkline Biologicals S.A. | Novel vaccine |
| MY134424A (en) | 2001-05-30 | 2007-12-31 | Saechsisches Serumwerk | Stable influenza virus preparations with low or no amount of thiomersal |
| WO2004022760A1 (en) * | 2002-09-04 | 2004-03-18 | Polymun Scientific Immunbiologische Forschung Gmbh | Generation of recombinant influenza virus using baculovirus delivery vector |
| KR20110132416A (ko) | 2004-04-05 | 2011-12-07 | 화이자 프로덕츠 인코포레이티드 | 미세유체화된 수중유 유화액 및 백신 조성물 |
| WO2005113756A1 (en) | 2004-05-14 | 2005-12-01 | Glaxosmithkline Biologicals S.A. | Method |
| AU2005245943A1 (en) | 2004-05-20 | 2005-12-01 | Id Biomedical Corporation | Process for the production of an influenza vaccine |
| CN101103103A (zh) * | 2004-11-19 | 2008-01-09 | 威斯康星旧生研究基金会 | 具有串联转录单位的重组流感病毒载体 |
| ES2526170T3 (es) | 2004-12-23 | 2015-01-07 | Medimmune, Llc | Línea celular MDCK no tumorigénica para propagar virus |
| NZ556061A (en) | 2004-12-24 | 2009-06-26 | Solvay Biologicals Bv | Rescue of influenza virus |
| FR2884255B1 (fr) | 2005-04-11 | 2010-11-05 | Vivalis | Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe |
| EP1917352A4 (en) | 2005-06-21 | 2009-03-25 | Medimmune Vaccines Inc | METHODS AND COMPOSITIONS FOR EXPRESSING HETEROLOGOUS PROTEASE |
| US8703095B2 (en) | 2005-07-07 | 2014-04-22 | Sanofi Pasteur S.A. | Immuno-adjuvant emulsion |
| ATE494906T1 (de) | 2005-11-01 | 2011-01-15 | Novartis Vaccines & Diagnostic | Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna |
| FR2896162B1 (fr) | 2006-01-13 | 2008-02-15 | Sanofi Pasteur Sa | Emulsion huile dans eau thermoreversible |
| CN101528941B (zh) | 2006-04-19 | 2014-03-12 | 米迪缪尼有限公司 | 在犬细胞中表达负义病毒rna的方法和组合物 |
| CA2664619C (en) | 2006-10-12 | 2012-12-11 | Glaxosmithkline Biologicals S.A. | Immunogenic compositions comprising an oil-in-water emulsion adjuvant containing a reduced amount of squalene, tocol and an emulsifying agent |
| JP2011506264A (ja) | 2006-12-06 | 2011-03-03 | ノバルティス アーゲー | インフルエンザウイルスの４つの株に由来する抗原を含むワクチン |
| EP2045323A1 (en) * | 2007-10-05 | 2009-04-08 | Avir Green Hills Biotechnology Research Development Trade Ag | Linear expression constructs for production of influenza virus particles |
| US9593329B2 (en) | 2007-10-08 | 2017-03-14 | Synthetic Genomics, Inc. | Assembly of large nucleic acids |
| CN101302499A (zh) | 2008-06-30 | 2008-11-12 | 中国科学院广州生物医药与健康研究院 | 一种流感病毒疫苗种子株的制备方法 |
| EP2233568A1 (en) | 2009-03-19 | 2010-09-29 | Avir Green Hills Biotechnology Research Development Trade AG | Novel method for generation of RNA virus |
-
2010
- 2010-07-30 WO PCT/IB2010/002137 patent/WO2011012999A1/en not_active Ceased
- 2010-07-30 CA CA2769673A patent/CA2769673A1/en not_active Abandoned
- 2010-07-30 CN CN201080041918.0A patent/CN102666860B/zh active Active
- 2010-07-30 JP JP2012522275A patent/JP2013500712A/ja not_active Withdrawn
- 2010-07-30 AU AU2010277310A patent/AU2010277310B2/en active Active
- 2010-07-30 CN CN201510264548.1A patent/CN104862335A/zh active Pending
- 2010-07-30 KR KR1020127005113A patent/KR20120039047A/ko not_active Withdrawn
- 2010-07-30 US US13/388,033 patent/US9821052B2/en active Active
- 2010-07-30 EP EP10754367.0A patent/EP2459722B1/en active Active
-
2015
- 2015-11-02 JP JP2015215655A patent/JP2016019547A/ja active Pending
-
2017
- 2017-07-28 JP JP2017146473A patent/JP6666311B2/ja active Active
- 2017-10-16 US US15/784,575 patent/US10610584B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kobayashi et al. | An improved reverse genetics system for mammalian orthoreoviruses | |
| Zhou et al. | Characterization of uncultivable bat influenza virus using a replicative synthetic virus | |
| JP2015119730A5 (enExample) | ||
| Sun et al. | Rapid construction of complex plant RNA virus infectious cDNA clones for agroinfection using a yeast-E. coli-Agrobacterium shuttle vector | |
| JP2019011344A5 (enExample) | ||
| JP2016509864A5 (enExample) | ||
| EA201791343A1 (ru) | Композиции и способы для конструирования вирусного генома in vitro | |
| Zhang et al. | Wheat yellow mosaic virus NIb interacting with host light induced protein (LIP) facilitates its infection through perturbing the abscisic acid pathway in wheat | |
| JP2010042030A5 (enExample) | ||
| RU2008101367A (ru) | Способы и композиции для экспрессии отрицательной смысловой вирусной рнк в собачьих клетках | |
| RU2008145226A (ru) | Способы и композиции для экспрессии антисмысловой вирусной рнк в клетках собаки | |
| Griffin et al. | Fitness determinants of influenza A viruses | |
| Geng et al. | Translation of plant RNA viruses | |
| Mostafa et al. | Efficient generation of recombinant influenza a viruses employing a new approach to overcome the genetic instability of HA segments | |
| AU2016203557B2 (en) | Plasmids and method for obtaining viral particles | |
| JP2016501020A5 (enExample) | ||
| Shao et al. | An efficient and rapid influenza gene cloning strategy for reverse genetics system | |
| WO2013030176A3 (en) | Live attenuated influenza virus | |
| Park et al. | Effects of HA and NA glycosylation pattern changes on the transmission of avian influenza A (H7N9) virus in guinea pigs | |
| Lee | Reverse genetics of influenza virus | |
| Feng et al. | Comparing the functions of equine and canine influenza H3N8 virus PA-X proteins: suppression of reporter gene expression and modulation of global host gene expression | |
| Yeo et al. | Peering into avian influenza a (H5N8) for a framework towards pandemic preparedness | |
| Kim et al. | Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus | |
| CN104195154A (zh) | 新城疫病毒Mukteswar中等毒力疫苗株反向遗传操作系统及其应用 | |
| Froggatt et al. | Influenza A virus segments five and six can harbor artificial introns allowing expanded coding capacity |